The clinical efficacy of artemether/lumefantrine (Coartem®)

Malaria Journal

Volumn 8, Issue SUPPL. 1, 2009, Pages

  Makanga, Michael ^a   Krudsood, Srivicha ^b  

^a European & Developing Countries Clinical Trials Partnership   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; MEFLOQUINE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG QUALITY; DRUG SAFETY; HUMAN; MALARIA; MIXED INFECTION; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION; AFRICA; ASIA; DRUG COMBINATION; REVIEW;

AFRICA; ANTIMALARIALS; ARTEMISININS; ASIA; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA; POLYMERASE CHAIN REACTION;

EID: 70350031256     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-S1-S5     Document Type: Article

References (55)

1. WHO guidelines for the treatment of malaria 2006. http://www.who.int/ malaria/docs/TreatmentGuidelines2006.pdf
2. Clinical pharmacokinetics and pharmacodynamics of artemether/ lumefantrine. NJ White M van Vugt F Ezzet, Clin Pharmacokinet 1999 37 105 125 10.2165/00003088-199937020-00002 10496300
3. The WHO prequalification project. World Health Organization, http://www.who.int/mediacentre/factsheets/fs278/en/index.html
4. The global portfolio of new antimalarial medicines under development. P Olliaro TNC Wells, Clin Pharmacol & Therapeutics 2009 85 584 595 10.1038/clpt.2009.51
5. Tablets for the treatment of malaria in patients with acute, uncomplicated infections due to Plasmodium falciparum or mixed infections including P. falciparum. NDA 22-268. M Cousin S Kummerer G Lefèvre AC Marrast D Stein M Weaver Advisory Committee Briefing Book. Coartem (artemether/lumefantrine), 2008 http://www.fda.gov/ohrms/dockets/ac/08/briefing/ 2008-4388b1-02-Novartis.pdf
6. WHO World Malaria Report 2008: Chapter 4 - Interventions to control malaria. http://www.who.int/malaria/wmr2008/MAL2008-Chap4-EN.pdf
7. Coartem®/Riamet® Basic Prescribing Information. Novartis Drug Regulatory Affairs, 2007
8. WHO Model List of Essential Medicines. http://www.who.int/medicines/ publications/08-ENGLISH-indexFINAL-EML15.pdf
9. WHO Model List of Essential Medicines for Children. http://www.who.int/ childmedicines/publications/EMLc%20(2).pdf
10. Efficacy of six doses of artemether/lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. M van Vugt P Wilairatana B Gemperli I Gathmann L Phaipun A Brockman C Luxemburger NJ White F Nosten S Looareesuwan, Am J Trop Med Hyg 1999 60 936 942 10403324
11. Artemether/lumefantrine for the treatment of multi-drug resistant falciparum malaria. M van Vugt S Looareesuwan P Wilairatana R McGready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386 (Pubitemid 30793838)
12. A clinical and pharmacokinetic trial of six doses of artemether/ lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefèvre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop Med Hyg 2001 64 247 256 11463111
13. Efficacy and safety of artemether/lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. C Falade M Makanga Z Premji CE Ortmann M Stockmeyer PI de Palacios, Trans R Soc Trop Med Hyg 2005 99 459 467 10.1016/j.trstmh.2004.09.013 15837358
14. Efficacy and safety of artemether/lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. S Abdulla I Sagara S Borrmann U D'Alessandro R Gonzlez M Hamel B Ogutu A Mårtensson J Lyimo H Maiga P Sasi A Nahum Q Bassat E Juma L Otieno A Björkman HP Beck K Andriano M Cousin G Lefèvre D Ubben Z Premji, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
15. Treatment of acute uncomplicated falciparum malaria with artemether/lumefantrine in non-immune populations: a safety, efficacy and pharmacokinetic study. C Hatz J Soto HD Nothdurft T Zoller T Weitzel L Loutan F Bricaire F Gay GD Burchard K Andriano G Lefèvre PI De Palacios B Genton, Am J Trop Med Hyg 2008 78 241 247 18256423
16. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. H Bukirwa A Yeka MR Kamya A Talisuna K Banek N Bakyaita JB Rwakimari PJ Rosenthal F Wabwire-Mangen G Dorsey SG Staedke, PLoS Clin Trials 2006 1 7 16871329 10.1371/journal.pctr.0010007
17. Combination therapy for uncomplicated falciparum malaria in Ugandan children. G Dorsey S Staedke TD Clark D Njama-Meya B Nzarubara C Maiteki-Sebuguzi C Dokomajilar MR Kamya PJ Rosenthal, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
18. Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. R Gürkov T Eshetu IB Miranda N Berens-Riha Y Mamo T Girma E Krause M Schmidt JM Hempel T Löscher, Malar J 2008 7 179 18796142 10.1186/1475-2875-7-179
19. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. AM Kabanywanyi A Mwita D Sumari R Mandike K Mugittu S Abdulla, Malar J 2007 6 146 17996121 10.1186/1475-2875-6-146
20. Artemether/lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. MR Kamya A Yeka H Bukirwa M Lugemwa JB Rwakimari SG Staedke AO Talisuna B Greenhouse F Nosten PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Clin Trials 2007 2 20 17525792 10.1371/journal.pctr.0020020 (Pubitemid 46860146)
21. Efficacy of artesunate plus amodiaquine versus that of artemether/lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. A Mårtensson J Strömberg C Sisowath MI Msellem JP Gil SM Montgomery P Olliaro AS Ali A Björkman, Clin Infect Dis 2005 41 1079 1087 10.1086/444460 16163624
22. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. A Mårtensson B Ngasala J Ursing M Isabel Veiga L Wiklund C Membi SM Montgomery Z Premji A Farnert A Bjorkman, J Infect Dis 2007 195 597 601 10.1086/510910 17230421
23. The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether/lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan. AO Mohamed EH Eltaib OA Ahmed SB Elamin EM Malik, Ann Trop Med Parasitol 2006 100 5 10 10.1179/136485906X86239 16417707
24. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether/lumefantrine in eastern Sudan. EA Mukhtar NB Gadalla S-EG El-zaki I Mukhtar FA Mansour A Babiker BB El-Sayed, Malar J 2007 6 92 17631681 10.1186/1475-2875-6-92 (Pubitemid 47224885)
25. Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether/lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 1474 1480 10.1016/S0140-6736(05)66417-3 15850631
26. Artemether/lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. A Yeka G Dorsey MR Kamya A Talisuna M Lugemwa JB Rwakimari SG Staedke PJ Rosenthal F Wabwire-Mangen H Bukirwa, PLoS ONE 2008 3 2390 18545692 10.1371/journal.pone. 0002390
27. Safety and efficacy of lumefantrine-artemether (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. M Mulenga J-P Van geertruyden L Mwananyanda V Chalwe F Moerman R Chilengi C Van Overmeir JC Dujardin U D'Alessandro, Malar J 2006 5 73 16923176 10.1186/1475-2875-5-73 (Pubitemid 44481293)
28. Effectiveness of co-artemether in an unsupervised outpatient setting for the treatment of falciparum malaria. S Toovey, Travel Med Infect Dis 2008 6 29 31 10.1016/j.tmaid.2007.08.007 18342270
29. Amodiaquine-artesunate vs artemether/lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. GO Adjei JA Kurtzhals OP Rodrigues M Alifrangis LC Hoegberg ED Kitcher EV Badoe R Lamptey BQ Goka, Malar J 2008 7 127 18620577 10.1186/1475-2875-7-127 (Pubitemid 352033070)
30. High efficacy of two artemisinin-based combinations (artemether/ lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. CO Falade AO Ogundele BO Yusuf OG Ademowo SM Ladipo, Trop Med Int Health 2008 13 635 643 18346028
31. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. B Faye JL Ndiaye D Ndiaye Y Dieng O Faye O Gaye, Malar J 2007 6 80 17570848 10.1186/1475-2875-6-80 (Pubitemid 47064368)
32. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. KA Koram B Abuaku N Duah N Quashie, Acta Trop 2005 95 194 203 10.1016/j. actatropica.2005.06.018 16054584
33. Artemether/lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. M Meremikwu A Alaribe R Ejemot A OyoIta J Ekenjoku C Nwachukwu D Ordu E Ezedinachi, Malar J 2006 5 43 16704735 10.1186/1475-2875-5-43 (Pubitemid 43865102)
34. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether/lumefantrine for the treatment of uncomplicated malaria. S Owusu-Agyei KP Asante R Owusu M Adjuik S Amenga-Etego DK Dosoo J Gyapong B Greenwood D Chandramohan, PLoS ONE 2008 3 2530 18575626 10.1371/journal.pone.0002530
35. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. I Sagara A Dicko A Djimde O Guindo M Kone Y Tolo MA Thera M Sogoba M Fofana A Ouattara M Sissoko HF Jansen OK Doumbo, Am J Trop Med Hyg 2006 75 630 636 17038684
36. Therapeutic efficacy and effects of artemether/lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. A Sowunmi GO Gbotosho CT Happi AA Adedeji FA Fehintola OA Folarin E Tambo BA Fateye, Am J Trop Med Hyg 2007 77 235 241 17690392
37. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. CJ Sutherland R Ord S Dunyo M Jawara CJ Drakeley N Alexander R Coleman M Pinder G Walraven GA Targett, PLoS Med 2005 2 92 15839740 10.1371/journal.pmed.0020092 (Pubitemid 40721079)
38. Artemether/lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomized non-inferiority trial. I Zongo G Dorsey N Rouamba H Tinto C Dokomajilar RT Guiguemde PJ Rosenthal JB Ouedraogo, Lancet 2007 369 491 498 10.1016/S0140-6736(07)60236-0 17292769
39. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether/lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. I Zongo G Dorsey N Rouamba C Dokomajilar Y Séré PJ Rosenthal JB Ouédraogo, Clin Infect Dis 2007 45 1453 1461 10.1086/522985 17990228
40. A randomised trial to assess the safety and efficacy of artemether/lumefantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. CI Fanello C Karema W van Doren C Van Overmeir D Ngamije U D'Alessandro, Trans R Soc Trop Med Hyg 2007 101 344 350 10.1016/j.trstmh.2006.06.010 17005222 (Pubitemid 46196260)
41. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. J-P Guthmann S Cohuet C Rigutto F Fortes N Saraiva J Kiguli J Kyomuhendo M Francis F Nol M Mulemba S Balkan, Am J Trop Med Hyg 2006 75 143 145 16837721
42. Efficacité de combinaisons thérapeutiques avec des dérivés de l'artémisinine dans le traitement de l'accès palustre non-complique au Burundi. A Ndayiragije D Niyungeko J Karenzo E Niyungeko M Barutwanayo A Ciza A Bosman R Moyou-Somo A Nahimana JP Nyarushatsi T Barihuta L Mizero J Ndaruhutse C Delacollette P Ringwald J Kamana, Trop Med Int Health 2004 9 673 679 10.1111/j.1365-3156.2004.01255.x 15189457
43. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. I van den Broek C Kitz S Al Attas F Libama M Balasegaram JP Guthmann, Malar J 2006 5 113 17125496 10.1186/1475-2875-5-113 (Pubitemid 44915803)
44. Supervised versus unsupervised intake of six-dose artemether/lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. P Piola C Fogg F Bajunirwe S Biraro F Grandesso E Ruzagira J Babigumira I Kigozi J Kiguli J Kyomuhendo L Ferradini W Taylor F Checchi JP Guthmann, Lancet 2005 365 1467 1473 10.1016/S0140-6736(05)66416-1 15850630
45. Comparative clinical trial of two-fixed combinations dihydroartemisinin- napthoquine-trimethoprim (DNP®) and artemether/lumefantrine (Coartem®/Riamet®) in the treatment of acute uncomplicated falciparum malaria in Thailand. S Krudsood K Chalermrut C Pengruksa S Srivilairit U Silachamroon S Treeprasertsuk S Kano GM Brittenham S Looareesuwan, Southeast Asian J Trop Med Public Health 2003 34 316 321 12971556
46. Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. C Rojanawatsirivej S Vijaykadga I Amklad P Wilairatna S Looareesuwan, Southeast Asian J Trop Med Public Health 2003 34 536 541 15115123
47. Therapeutic efficacy of artemether/lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. JM Stohrer S Dittrich V Thongpaseuth V Vanisaveth R Phetsouvanh S Phompida F Monti EM Christophel N Lindegardh A Annerberg T Jelinek, Trop Med Int Health 2004 9 1175 1183 10.1111/j.1365-3156. 2004.01320.x 15548313
48. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether/lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. M Mayxay M Khanthavong N Lindegårdh S Keola M Barends T Pongvongsa R Yapom A Annerberg S Phompida R Phetsouvanh NJ White PN Newton, Clin Infect Dis 2004 39 1139 1147 10.1086/424512 15486837
49. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. A Ratcliff H Siswantoro E Kenangalem R Maristela RM Wuwung F Laihad EP Ebsworth NM Anstey E Tjitra RN Price, Lancet 2007 369 757 765 17336652 10.1016/S0140- 6736(07)60160-3 (Pubitemid 46335820)
50. A randomized trial of artemether/lumefantrine versus mefloquine- artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. R Hutagalung L Paiphun EA Ashley R McGready A Brockman KL Thwai P Singhasivanon T Jelinek NJ White FH Nosten, Malar J 2005 4 46 16179089 10.1186/1475-2875-4-46 (Pubitemid 41455936)
51. Efficacy of chloroquine + sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. IV van den Broek UA Maung A Peters L Liem M Kamal M Rahman MR Rahman AM Bangali S Das M Barends AM Faiz, Trans R Soc Trop Med Hyg 2005 99 727 735 10.1016/j.trstmh. 2005.02.007 16095643
52. Therapeutic efficacy of artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh. R Haque K Thriemer Z Wang K Sato Y Wagatsuma MA Salam S Akther J Akter M Fukuda RS Miller H Noedl, Am J Trop Med Hyg 2007 76 39 41 17255226
53. Comparison of artemether/lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Eastern Nepal. S Thapa J Hollander M Linehan J Cox-Singh MB Bista GD Thakur WA Davis TM Davis, Am J Trop Med Hyg 2007 77 423 430 17827354
54. Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis. FH Jansen E Lesaffre LK Penali MJ Zattera H Die-Kakou E Bissagnene, Am J Trop Med Hyg 2007 77 1005 1009 18165512
55. Safety profile of Coartem® - the evidence base. C Falade C Manyando, Malar J 2009 8 Suppl 1 8